View of Prolonged response for 43 cycles of trastuzumab entansine (T‑DM1) in a patient with metastatic breast cancer with HER2 overexpression

Return to Article Details Prolonged response for 43 cycles of trastuzumab entansine (T‑DM1) in a patient with metastatic breast cancer with HER2 overexpression Download Download PDF